<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="MOESM1">
 <media xlink:href="12951_2020_611_MOESM1_ESM.docx" xmlns:xlink="http://www.w3.org/1999/xlink">
  <caption>
   <p>
    <bold>Additional file 1: Figure S1.</bold> Size distribution plot of (A) PoGNP (B) sGNP (C) AgNP; Polydispersity index (PDI) of each nanoparticle was 0.058, 0.032 and 0.048, respectively. 
    <bold>Figure S2.</bold> MDCK cell viability after treatment with (A) PoGNP (B) sGNP and (C) AgNP at various nanoparticle concentrations. 
    <bold>Figure S3.</bold> MDCK cell viability assay of PoGNP treatment for 10 min and 60 min on H9N2 virus infected cell. (viral titer: 106 EID50/mL, dotted line: positive control (P.C.)). 
    <bold>Figure S4.</bold> Standard curve of EID value derived by real-time RT-PCR. 
    <bold>Figure S5.</bold> MDCK cell viability after infection with TECP-treated H3N2 virus. Upper line: negative control (N.C.), lower line: positive control (P.C.). (viral titer: 10
    <sup>6</sup> EID
    <sub>50</sub>/mL).
   </p>
  </caption>
 </media>
</supplementary-material>
